K-numberK250308
Device nameHair Growth Device (KCA441-200, KCA441-120, KCA441-88, KCA441-56, KCA441-200S, KCA441-120S, KCA441-88S, KCA441-56S, KCA451-200, KCA451-120, KCA451-88, KCA451-56, KCA451-200S, KCA451-120S, KCA451-88S, KCA451-56S)
ApplicantDongguan Boyuan Intelligent Technology Co.,Ltd
Product codeOAP
Device classClass II
Decision dateApr 29, 2025
DecisionSubstantially Equivalent
Regulation890.5500
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Hair Growth Device is a portable, low-level laser therapy (LLLT) helmet used to promote hair growth in patients with androgenetic alopecia. It uses 650 nm visible red laser diodes (5 mW each) distributed throughout the helmet to treat the entire scalp. The device is indicated for females with Ludwig-Savin Classifications I-II and males with Norwood-Hamilton Classifications IIa-V, across Fitzpatrick skin types I-IV, and is sold over-the-counter.

Technological characteristics

The subject device uses 56, 88, 120, or 200 laser diodes at 650 nm ±20 nm wavelength, delivering 5 mW per diode with treatment duration of 30 minutes every 2 days for 16 weeks. Predicate devices use similar 650 nm wavelengths but vary in number of diodes (predicate: 200; references: 51–272) and treatment protocols. All devices are Class 3R per IEC60825-1 and operate at similar irradiance and fluence ranges, though the subject device has multiple models with different laser counts to accommodate different treatment intensities.

Test standards cited

IEC 60601-1 (medical device safety), IEC 60601-1-2 (EMC), IEC 60825-1 (laser safety), IEC 60601-1-11 (home healthcare), ISO 10993-5 and ISO 10993-10 (biocompatibility). The submission also references software validation, electromagnetic compatibility and electrical safety testing, laser safety verification, and performance testing.

Substantial equivalence argument

The subject device has identical intended use and mechanism of action (LLLT at 650 nm for androgenetic alopecia) as the predicate iHelmet and reference devices. Although the subject device offers multiple laser counts (56–200) compared to the predicate's single 200-diode configuration, the applicant argues this creates a range of fluence and irradiance values that fall within or overlap the predicate devices' specifications, making them therapeutically equivalent. Dimensional and weight variations are claimed not to affect safety or effectiveness because all devices comply with the same IEC 60601-1 standards. Non-clinical testing (biocompatibility, EMC, laser safety, performance) demonstrated compliance with predefined acceptance criteria without clinical data.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →